Ginkgo Biloba vs Omega-3 (EPA/DHA) — Which Should You Take?
Ginkgo Biloba Benefits
Omega-3 (EPA/DHA) Benefits
Ginkgo Biloba Side Effects
Omega-3 (EPA/DHA) Side Effects
Can You Take Ginkgo Biloba and Omega-3 (EPA/DHA) Together?
In most cases, Ginkgo Biloba and Omega-3 (EPA/DHA) can be taken together safely. However, always check the interactions section of each supplement and consult a healthcare professional if you take medication or have existing health conditions.
Ginkgo Biloba: Blood thinners (warfarin, aspirin)
Ginkgo Biloba: Antiplatelet medications
Omega-3 (EPA/DHA): Blood thinners (warfarin, aspirin) — increases bleeding risk
Omega-3 (EPA/DHA): Blood pressure medications — additive effect
Which Should You Choose?
Choose Ginkgo Biloba if your primary goal is: enhanced memory and cognitive function. Choose Omega-3 (EPA/DHA) if your primary goal is: heart health — reduces triglycerides.
Affiliate links — we may earn a small commission at no extra cost to you.
Frequently Asked Questions
Is Ginkgo Biloba better than Omega-3 (EPA/DHA)?
It depends on your goals. Ginkgo Biloba and Omega-3 (EPA/DHA) serve different purposes and are often taken together.
Can I take Ginkgo Biloba and Omega-3 (EPA/DHA) together?
In most cases, yes. Ginkgo Biloba and Omega-3 (EPA/DHA) can be taken together safely. However, always check for specific interactions and consult a healthcare professional if you take medication.
What is the best time to take Ginkgo Biloba?
Divided doses with meals
What is the best time to take Omega-3 (EPA/DHA)?
With meals containing fat
What are the side effects of Ginkgo Biloba?
Mild headache. Dizziness or vertigo. Gastrointestinal upset. Allergic reactions (rare). Increased bleeding risk at high doses.
What are the side effects of Omega-3 (EPA/DHA)?
Fish burps (use enteric-coated capsules). Mild blood thinning at high doses. Rare: fishy aftertaste.
How We Compare Supplements
This comparison is based on published clinical research, peer-reviewed studies from PubMed, and established nutritional science. We evaluate dosages based on clinically-effective amounts, not manufacturer recommendations. Benefits listed have at least moderate evidence from human studies. When evidence is limited or conflicting, we note this.